StreetInsider com - Analyst Comments streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Equities analysts expect VistaGen Therapeutics, Inc. (NASDAQ:VTGN – Get Rating) to report earnings per share of ($0.06) for the current quarter, Zacks reports. Two analysts have provided estimates for VistaGen Therapeutics’ earnings. VistaGen Therapeutics posted earnings per share of ($0.20) during the same quarter last year, which would suggest a positive year over year growth […]
VistaGen to Participate in Upcoming June Investor Conferences streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
AN2 Therapeutics, Inc (ANTX) Appoints Maggie FitzPatrick to Its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
VistaGen Therapeutics is one step closer to launching its nasal spray for social anxiety after the FDA said it does not need an additional study testing the drug's potential to be abused.